CS MEDICA provides patent update
CS MEDICA (”CS MEDICA” or the ”Company”) announces today that the Company has completed all PCT continuation patents, in total 7 patents applications covering 11 products.CS MEDICA strives toward granting patent acceptance on all present and future treatment products. All CS MEDICA’s treatment products (topical and oral) as of today are patented in accordance with PCT (Patent Cooperation Treaty), covering 153 nations across the globe. The Company currently has seven proceeding patents that are filed and pending. The 15[th] of September 2022 the USA national patent application on Arthritis &